PerkinElmer announces Caliper Life Sciences takeover

PerkinElmer has announced that it will be acquiring Caliper Life Sciences, a developer of imaging and detection solutions for life sciences research and diagnostics.

A $600 million (379.4 million pounds) agreement has been reached that will see PerkinElmer enhance its position in the human and environmental health-related imaging market.

Caliper Life Sciences' expertise extends to areas such as molecular, cellular, animal and tissue analysis, world-leading microfluidics platforms and high-calibre sample preparation technologies.

Robert Friel, chairman and chief executive officer at PerkinElmer, said the proven leadership and talent of Caliper's workforce will also enhance its operations.

"The research and development, application expertise and intellectual property of the combined organisation will provide our customers with enhanced knowledge and services and a strong pipeline of innovation," he added.

Last month, PerkinElmer published its financial report for the second quarter of 2011, during which it experienced a 14 percent year-on-year revenue increase.